For further information contact:

 

Kristin Gray 

Phone: 780-809-1224

kgray@bowragroup.com

 

 

Destiny Bioscience Global Corp. and Destiny Biotech Inc.

 

Overview

 

The Bowra Group Inc. was appointed Receiver Manager (the “Receiver”) of Destiny Bioscience Global Corp. and Destiny Biotech Inc.. ( collectively the “Companies”) on May 22, 2020 pursuant to a Court Order of the Court of Queen’s Bench of Alberta.

 

Destiny Bioscience Global Corp. (“Destiny”) is a private company originally incorporated on May 28, 2014, under the laws of the Province of Alberta. Destiny is a science-based cannabis genetics and cultivation inputs research and development company. Destiny constructed and operated out of a facility in Nisku, Alberta. Phase I of the Nisku facility is a completed purpose-built 90,000 sq. ft. organics building. Phase II is a state-of-the-art 194,065 sq. ft. genetics Lab still under construction. Destiny Biotech Inc. is a 100% owned subsidiary of Destiny.

Application Materials: 

Emergency Hearing Order – May 8, 2020

Consent to Act – May 12, 2020

Receivership Application – May 12, 2020

Brief of Synergy for Receivership Application– May 12, 2020

Affidavit of Tim Varughese – May 12, 2020

Affidavit of Tim Varughese in opposition of application – May 15, 2020

Brief of Synergy in Response to opposition of application – May 15, 2020

Court Orders: 
 

Receivership Order – May 22, 2020 (2003 07758)

Receivership Order – May 22, 2020 (2003 07757)

 

 

 

Vancouver Office: 

PO Box 72, Bentall One

505 Burrard Street, Suite 430

Vancouver, B.C.  V7X 1M3

Tel: 604 689 8939

Fax: 604 689 8584

Edmonton Office: 

TD Tower

Suite 1411 – 10088 102 Avenue

Edmonton, AB T5J 2Z1

Tel: 780 809 1224

Fax: 780 705 1946

 

 
  • Facebook Basic Black
  • LinkedIn Basic Black
  • Twitter Basic Black

© The Bowra Group.